ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #860Top JournalHybrid

European Journal of Cancer

Acronym:ejc
•
Abbreviation (ISO):EUR. J. CANCER
•
Identifier (ISSN):0959-8049(Print)/1879-0852(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
7.9↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for European Journal of Cancer

WoS Q1
4710137.1920186.6820197.2820209.16202110.020228.420237.620247.120257.92026
Annual Impact Factor Metric
Current (2026):7.9
Scopus SJR & RankScopus Q1
2.692
#860

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
263

263 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
436articles/year
43.23% Gold OA•86.95% Original Research

Aims & Scope

The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention. The Journal now has online submission for authors.

Topics Covered (Recognized by AI)
Medicine96.7%Biology89.1%Internal medicine85%Genetics82.5%Cancer60.9%Oncology49.2%Pathology43.5%Chemistry42.2%Surgery41.3%Biochemistry34.1%Cancer research29.1%Chemotherapy22.2%Breast cancer21.9%Immunology21.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank45/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank39/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7.9
Articles / Year645
Total Citations154
2025
IF7.1
Articles / Year700
Total Citations2,380
2024
IF7.6
Articles / Year1,361
Total Citations5,288
2023
IF8.4
Articles / Year501
Total Citations7,692
2022
IF10.002
Articles / Year1,223
Total Citations13,726

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #860Scopus Q1SCImago Profile
Scopus Coverage:1990-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.692

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.50

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,006 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,409
3-Year Documents1,591
Citable Documents1,381

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Journal of Cancer (acronym: ejc, abbr: EUR. J. CANCER, ISSN: 0959-8049) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England since 1990. The periodical holds a Journal Impact Factor (JIF) of 7.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.692 (Q1), an H-index of 263.

The journal enforces rigorous peer evaluation with an average review speed of 5.3周, a publication frequency of Semimonthly, an annual output of approximately 436 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,006 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
English
Frequency
Semimonthly
Founding Year
1990
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 93fb8d59-1273-4e86-b46d-4d94d45c1281
Database Updated: 2026-10-16